Valuation: Incyte Corporation

Market Cap 2.31TCr 2.03TCr 1.89TCr 1.74TCr 3.26TCr 2,24000Cr 3.32TCr 23TCr 8.82TCr 1,09300Cr 8.68TCr 8.5TCr 3,79100Cr P/E 2026 *
55.9x
P/E 2027 * 15.8x
Enterprise Value 1.87TCr 1.64TCr 1.52TCr 1.4TCr 2.63TCr 1,80600Cr 2.68TCr 18TCr 7.11TCr 88TCr 7TCr 6.85TCr 3,05700Cr EV / Sales 2026 *
3.27x
EV / Sales 2027 * 2.81x
Free-Float
98.11%
Yield 2026 *
-
Yield 2027 * -
1 day+0.78%
1 week+0.03%
Current month+2.94%
1 month+11.77%
3 months+22.23%
6 months+14.41%
Current year+18.14%
1 week 114.5
Extreme 114.505
119.6
1 month 104.49
Extreme 104.49
119.6
Current year 89.25
Extreme 89.25
119.6
1 year 69.7
Extreme 69.695
119.6
3 years 50.27
Extreme 50.27
119.6
5 years 50.27
Extreme 50.27
119.6
10 years 50.27
Extreme 50.27
153.15
Manager TitleAgeSince
Chief Executive Officer 58 26/06/2025
Director of Finance/CFO 57 04/05/2026
President 62 05/06/2023
Director TitleAgeSince
Chairman 59 26/06/2025
Director/Board Member 72 20/01/2015
Director/Board Member 64 20/01/2015
Date Insider Type Main position Quantity % Market Cap.
16/07/26 Free

EVP, Human Resources

39,018 0.0195%
16/07/26 Free

Principal Accounting Officer

6,913 0.0035%
16/07/26 Sell

Chief Technology Officer

-78,469 0.0393%
Change 5-day change 1-year change 3-year change Capi.($)
+0.78%+0.03%+65.07%+83.88% 2.31TCr
+0.11%-3.98%+13.89%-10.34% 6.63TCr
-0.12%+3.10%+40.83%+196.27% 5.29TCr
+0.51%+37.90%+37.90%+37.90% 4.3TCr
-1.86%-4.93%-56.15%-56.66% 3.95TCr
+1.46%-3.97%+53.17%-27.57% 2.92TCr
-1.81%-9.71%+64.46%-53.65% 2.3TCr
-1.30%-6.18%+3.94%+177.59% 2.05TCr
-1.04%+0.53%+69.40%+119.96% 1.66TCr
+0.33%+3.28%+79.54%+149.49% 1.62TCr
Average -0.20%-1.90%+37.21%+61.69% 3.3TCr
Weighted average by Cap. -0.17%-1.51%+28.93%+51.56%

Financials

2026 *2027 *
Net sales 570.99Cr 502.19Cr 466.53Cr 429.08Cr 804.67Cr 55TCr 819.09Cr 5.58TCr 2.18TCr 27TCr 2.14TCr 2.1TCr 94TCr 615.65Cr 541.47Cr 503.02Cr 462.64Cr 867.6Cr 60TCr 883.16Cr 6.02TCr 2.35TCr 29TCr 2.31TCr 2.26TCr 1,00900Cr
Net income 43Cr 38Cr 35Cr 32Cr 61Cr 4.17TCr 62Cr 420.23Cr 163.91Cr 2.03TCr 161.47Cr 157.98Cr 7.05TCr 152.72Cr 134.32Cr 124.78Cr 114.77Cr 215.22Cr 15TCr 219.08Cr 1.49TCr 582.02Cr 7.21TCr 573.36Cr 560.96Cr 25TCr
Net Debt -448Cr -394.01Cr -366.04Cr -336.65Cr -631.33Cr -43TCr -642.65Cr -4.38TCr -1.71TCr -21TCr -1.68TCr -1.65TCr -73TCr -585.79Cr -515.2Cr -478.62Cr -440.2Cr -825.51Cr -57TCr -840.31Cr -5.72TCr -2.23TCr -28TCr -2.2TCr -2.15TCr -96TCr
Logo Incyte Corporation
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).
Employees
2,844
Date Price Change Volume
24/26/24 $116.69 +0.78% 9,49,406
22/26/22 $115.79 -1.36% 9,98,480
21/26/21 $117.39 +1.50% 19,06,845
20/26/20 $115.65 -1.36% 12,57,145
17/26/17 $117.25 +0.51% 22,32,513
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
115.79USD
Average target price
114.55USD
Spread / Average Target
-1.07%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INCY Stock